Latest Cost Management News

Qualitas Limited reports robust interim results for the six months to December 2025, driven by strong deployment and expanding investor mandates, reaffirming its FY26 guidance.

Qualitas Limited has delivered a standout first half of FY26, posting a 30% rise in normalised net profit before tax and record investment deployment, reinforcing its position in Australia’s alternative investment sector.

Qualitas Real Estate Income Fund reported a robust 33.7% increase in net assets to over $1 billion and a 5% rise in operating profit for the half-year ended December 2025, driven by strategic capital raisings and strong portfolio management.

Contact Energy Limited has reported a striking 43.9% increase in net profit for the half-year ending December 2025, even as revenue fell by 5.3%. The company’s acquisition of Manawa Energy Limited has boosted its net tangible assets, underpinning a healthy interim dividend.

GWA Group Limited reported solid half-year growth in revenue and earnings, driven by volume gains and strategic initiatives including a new AI partnership. The company also lifted its interim dividend, signalling confidence despite mixed market conditions ahead.

Ansell Limited reported a robust 61.5% surge in net profit for the first half of FY26, driven by operational efficiencies and strategic acquisitions, while announcing a planned CEO transition.

BlueScope Steel reported a robust first half of FY2026 with underlying EBIT soaring 81% to $557.5 million and announced a $3.00 per share shareholder return plan, while decisively rejecting a $30 per share takeover proposal.

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Takeover chatter lit up Pepper Money, while Identitii ran hard after a regulator stepped in. At the other end, AMP slid despite higher profit, as investors weighed leadership change and legal costs.

AVITA Medical closed 2025 with steady revenue growth and over 80% gross margin, setting the stage for a confident revenue forecast of up to US$85 million in 2026. The company also secured a new debt facility with improved terms, underpinning its growth ambitions.

AVITA Medical reported steady Q4 losses amid reimbursement challenges but achieved 11% revenue growth for 2025 and secured a $60 million credit facility to fuel future expansion.

Alkane Resources has reported record-breaking financial and operational results for the first half of FY2026, driven by strong gold and antimony production across its expanded three-mine portfolio. The company’s robust cash flow and profit position set a confident tone for meeting full-year guidance.